Results 151 to 159 of about 1,612 (159)

Can previously injected botulinum toxin cause paradoxical masseter muscle rigidity after administration of a nondepolarizing neuromuscular blocking agent?

Canadian Journal of Anesthesia/Journal canadien d'anesthésie, 2023
Ji Yung Lee, Kwon Hui Seo
openaire   +2 more sources

Factors Affecting Administration of Nondepolarizing Neuromuscular Blocking Agents

ASA Refresher Courses in Anesthesiology, 1980
openaire   +2 more sources

Are nondepolarizing neuromuscular blocking agents truly a risk factor for late-onset ventilator-associated pneumonia?

Intensive Care Medicine, 2005
Dave A. Dongelmans, Marcus J. Schultz
openaire   +2 more sources

Neostigmine: How Much Is Necessary for Patients Who Receive a Nondepolarizing Neuromuscular Blocking Agent?

Anesthesiology, 2010
openaire   +3 more sources

Feasibility of intraoperative neuromonitoring during thyroid surgery after administration of nondepolarizing neuromuscular blocking agents

Yearbook of Anesthesiology and Pain Management, 2011
openaire   +2 more sources

Cisatracurium: a new nondepolarizing neuromuscular blocking agent.

Connecticut medicine, 1996
C A, Owens, J, Brakoniecki
openaire   +1 more source

BW444U

Anesthesiology, 1979
John J. Savarese, William B. Wastila
openaire   +2 more sources

[Neuromuscular blockade. Dosage of nondepolarizing agents to risk-group patients].

Ugeskrift for laeger, 1995
P E, Holst, D, Ostergaard, J, Bonde
openaire   +1 more source

Faculty Opinions recommendation of Nondepolarizing neuromuscular blocking agents, reversal, and risk of postoperative pneumonia.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature, 2016
openaire   +1 more source